Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC

NCT06467617 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Adebrelimab plus albumin-bound paclitaxel, carboplatin and recaticimab

Sponsor

Beijing Chest Hospital, Capital Medical University